AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DARUNAVIR ETHANOLATE

10 registrations across 3 African markets— 10 active

Markets with DARUNAVIR ETHANOLATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
PREZISTA 150 mg🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJul 2028
PREZISTA 75 mg🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJul 2028
DARUNAVIR-400🇷🇼RwandaCIPLA LIMITEDactiveAug 2026
DARUNAVIR)-600🇷🇼RwandaCIPLA LIMITEDactiveAug 2026
ZADURNA🇿🇦South AfricaViatris Healthcare (Pty) LtdactiveJan 1900
DURANAVIR RITONAVIR 450 mg MYLAN🇿🇦South AfricaViatris Healthcare (Pty) LtdactiveJan 1900
DARUNAVIR ETHANOLATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaCIPLA LTD.active
DARUNAVIR ETHANOLATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaCIPLA LTD.active
DARUNAVIR ETHANOLATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaCIPLA LTD.active
DARUNAVIR ETHANOLATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaCIPLA LTD.active

DARUNAVIR ETHANOLATE in Africa — Regulatory Overview

DARUNAVIR ETHANOLATE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, South Africa, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.